| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |